MV
Therapeutic Areas
Korsana Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| KRSA-028 | Alzheimer's Disease | Pre-clinical |
Leadership Team at Korsana Biosciences
JV
Jonathan Violin
Chief Executive Officer
KB
Kyle Breidenstine
SVP, Finance
MZ
Maddy Zeylikman
General Counsel